| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |